ClinicalTrials.gg
Enrolling by invitationNCT01055054Updated Nov 5, 2026

Bariatric Surgery Registry

An observational study in Obesity, Morbid, sponsored by Virginia Commonwealth University. Enrolling by invitation at 1 site in United States. Open to participants aged 12 Years to 75 Years. Per ClinicalTrials.gov, last updated 2026-11-05.

Sponsored by Virginia Commonwealth University · Observational

How we know

Updated Nov 5, 2026Primary completion movedStudy completion movedGo to Updates ↓

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Study type
Observational
Model
Cohort
Time perspective
Prospective
Enrollment
8,000
Ages
12 Years to 75 Years
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-22

Among 213 studies in Obesity, Morbid with a site in United States — 28 open to participants now, 36 under way, 1 of them phase 3. Obesity, Morbid · United States.

Planned enrollment
2nd of 63
8,000 · median 50
Started
1980
the only one that year
Observational
63 of 213
10 open now
Primary completion
2027-10
later than 17 of 34 live
Registered
56th of 213
by date

Among the 213 studies in Obesity, Morbid with a site in United States, this one is the 2nd largest by planned enrollment of the 63 observational ones that give a count, is the only one that started in 1980, is one of 63 observational ones, reaches primary completion later than 17 of the 34 other live ones, and was the 56th registered.

Obesity, Morbid

941 studies on the registry are indexed under Obesity, Morbid; 162 are open to participants now.

Browse Obesity, Morbid studies →

Open to participants now

28 of the 213 studies in Obesity, Morbid with a site in United States are open now. Recruiting first, the newest first:

23 more — sign in →

All 28 open studies →

A study can be open while its sites in United States have not opened yet or have stopped. Only those recruiting at a site in United States →

Who these studies take

Of the 109 Obesity, Morbid studies recruiting now, 21 (19%) set no upper age limit and 83 (76%) stop at 75 or younger; 8 take children under 18; 9 take healthy volunteers.

This study: 12 Years to 75 Years · all sexes · no healthy volunteers.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 213 studies in Obesity, Morbid with a site in United States, or all of them as a file.
02

Study summary

Periodic analyses of our extensive database with regards to different surgical procedures for severe obesity and different obesity co-morbidities will be of benefit to our severely obese patients as well as to others world-wide.

03

Conditions studied

  • Obesity, Morbid

Browse trials for

Keywords

  • bariatrics
04

Who can participate

Ages eligible
12 Years to 75 Years
Sexes eligible
All
Accepts healthy volunteers
No
Sampling method
Non-probability sample

Study population

Patients who have undergone bariatric surgical procedures at the Virginia Commonwealth University (VCU) Medical Center.

Eligibility criteria

Inclusion Criteria:

  • Clinical diagnosis of morbid obesity
  • Have undergone a bariatric surgical procedure at the VCU Medical Center
05

Study design

Observational model
Cohort
Time perspective
Prospective
Enrollment
8,000 participants (estimated)
06

What researchers measure

Primary outcomes

  1. weight loss

    Time frame: 1 year, 5 years

Secondary outcomes

  1. surgical mortality

    Time frame: 90 day post-surgery

  2. surgical morbidity

    Time frame: 90 day post-surgery

  3. resolution of co-morbidities

    Time frame: 1 year, 5 years

07

Study locations

1 site
08

References and documents

Publications

  • Sugerman HJ, Fairman RP, Baron PL, Kwentus JA. Gastric surgery for respiratory insufficiency of obesity. Chest. 1986 Jul;90(1):81-6. doi: 10.1378/chest.90.1.81. PubMed 3720390 ↗
  • Sugerman HJ, Starkey JV, Birkenhauer R. A randomized prospective trial of gastric bypass versus vertical banded gastroplasty for morbid obesity and their effects on sweets versus non-sweets eaters. Ann Surg. 1987 Jun;205(6):613-24. doi: 10.1097/00000658-198706000-00002. PubMed 3296971 ↗
  • Sugerman HJ, Baron PL, Fairman RP, Evans CR, Vetrovec GW. Hemodynamic dysfunction in obesity hypoventilation syndrome and the effects of treatment with surgically induced weight loss. Ann Surg. 1988 May;207(5):604-13. doi: 10.1097/00000658-198805000-00015. PubMed 3377570 ↗
  • Sugerman HJ, Londrey GL, Kellum JM, Wolf L, Liszka T, Engle KM, Birkenhauer R, Starkey JV. Weight loss with vertical banded gastroplasty and Roux-Y gastric bypass for morbid obesity with selective versus random assignment. Am J Surg. 1989 Jan;157(1):93-102. doi: 10.1016/0002-9610(89)90427-3. PubMed 2910132 ↗
  • Sugerman HJ, Fairman RP, Sood RK, Engle K, Wolfe L, Kellum JM. Long-term effects of gastric surgery for treating respiratory insufficiency of obesity. Am J Clin Nutr. 1992 Feb;55(2 Suppl):597S-601S. doi: 10.1093/ajcn/55.2.597s. PubMed 1733136 ↗
  • Sanyal AJ, Sugerman HJ, Kellum JM, Engle KM, Wolfe L. Stomal complications of gastric bypass: incidence and outcome of therapy. Am J Gastroenterol. 1992 Sep;87(9):1165-9. PubMed 1519574 ↗
  • Sugerman HJ, Sugerman EL, Wolfe L, Kellum JM Jr, Schweitzer MA, DeMaria EJ. Risks and benefits of gastric bypass in morbidly obese patients with severe venous stasis disease. Ann Surg. 2001 Jul;234(1):41-6. doi: 10.1097/00000658-200107000-00007. PubMed 11460821 ↗
  • DeMaria EJ, Sugerman HJ, Kellum JM, Meador JG, Wolfe LG. Results of 281 consecutive total laparoscopic Roux-en-Y gastric bypasses to treat morbid obesity. Ann Surg. 2002 May;235(5):640-5; discussion 645-7. doi: 10.1097/00000658-200205000-00005. PubMed 11981209 ↗
  • DeMaria EJ, Schweitzer MA, Kellum JM, Meador J, Wolfe L, Sugerman HJ. Hand-assisted laparoscopic gastric bypass does not improve outcome and increases costs when compared to open gastric bypass for the surgical treatment of obesity. Surg Endosc. 2002 Oct;16(10):1452-5. doi: 10.1007/s00464-001-8321-5. Epub 2002 Jun 14. PubMed 12063573 ↗
  • Kothari SN, DeMaria EJ, Sugerman HJ, Kellum JM, Meador J, Wolfe L. Lap-band failures: conversion to gastric bypass and their preliminary outcomes. Surgery. 2002 Jun;131(6):625-9. doi: 10.1067/msy.2002.124879. PubMed 12075174 ↗
  • Sugerman HJ, Sugerman EL, DeMaria EJ, Kellum JM, Kennedy C, Mowery Y, Wolfe LG. Bariatric surgery for severely obese adolescents. J Gastrointest Surg. 2003 Jan;7(1):102-108. doi: 10.1016/S1091-255X(02)00125-7. PubMed 12559191 ↗
  • Sugerman HJ, Wolfe LG, Sica DA, Clore JN. Diabetes and hypertension in severe obesity and effects of gastric bypass-induced weight loss. Ann Surg. 2003 Jun;237(6):751-6; discussion 757-8. doi: 10.1097/01.SLA.0000071560.76194.11. PubMed 12796570 ↗
  • Fernandez AZ Jr, DeMaria EJ, Tichansky DS, Kellum JM, Wolfe LG, Meador J, Sugerman HJ. Experience with over 3,000 open and laparoscopic bariatric procedures: multivariate analysis of factors related to leak and resultant mortality. Surg Endosc. 2004 Feb;18(2):193-7. doi: 10.1007/s00464-003-8926-y. Epub 2003 Dec 29. PubMed 14691697 ↗
  • Fernandez AZ Jr, Demaria EJ, Tichansky DS, Kellum JM, Wolfe LG, Meador J, Sugerman HJ. Multivariate analysis of risk factors for death following gastric bypass for treatment of morbid obesity. Ann Surg. 2004 May;239(5):698-702; discussion 702-3. doi: 10.1097/01.sla.0000124295.41578.ab. PubMed 15082974 ↗
  • Sugerman HJ, DeMaria EJ, Kellum JM, Sugerman EL, Meador JG, Wolfe LG. Effects of bariatric surgery in older patients. Ann Surg. 2004 Aug;240(2):243-7. doi: 10.1097/01.sla.0000133361.68436.da. PubMed 15273547 ↗
  • Bond DS, Evans RK, Wolfe LG, Meador JG, Sugerman HJ, Kellum JM, Demaria EJ. Impact of self-reported physical activity participation on proportion of excess weight loss and BMI among gastric bypass surgery patients. Am Surg. 2004 Sep;70(9):811-4. PubMed 15481300 ↗
  • Tichansky DS, DeMaria EJ, Fernandez AZ, Kellum JM, Wolfe LG, Meador JG, Sugerman HJ. Postoperative complications are not increased in super-super obese patients who undergo laparoscopic Roux-en-Y gastric bypass. Surg Endosc. 2005 Jul;19(7):939-41. doi: 10.1007/s00464-004-8929-3. Epub 2005 May 5. PubMed 15920681 ↗
  • Carmody BJ, Sugerman HJ, Kellum JM, Jamal MK, Johnson JM, Carbonell AM, Maher JW, Wolfe LG, DeMaria EJ. Pulmonary embolism complicating bariatric surgery: detailed analysis of a single institution's 24-year experience. J Am Coll Surg. 2006 Dec;203(6):831-7. doi: 10.1016/j.jamcollsurg.2006.08.020. Epub 2006 Oct 25. PubMed 17116551 ↗
  • Carbonell AM, Wolfe LG, Meador JG, Sugerman HJ, Kellum JM, Maher JW. Does diabetes affect weight loss after gastric bypass? Surg Obes Relat Dis. 2008 May-Jun;4(3):441-4. doi: 10.1016/j.soard.2007.10.001. Epub 2007 Dec 11. PubMed 18065289 ↗
  • Ali MR, Tichansky DS, Kothari SN, McBride CL, Fernandez AZ Jr, Sugerman HJ, Kellum JM, Wolfe LG, DeMaria EJ. Validation that a 1-year fellowship in minimally invasive and bariatric surgery can eliminate the learning curve for laparoscopic gastric bypass. Surg Endosc. 2010 Jan;24(1):138-44. doi: 10.1007/s00464-009-0550-z. Epub 2009 Jun 11. PubMed 19517173 ↗
  • Evans RK, Bond DS, Demaria EJ, Wolfe LG, Meador JG, Kellum JM. Initiation and progression of physical activity after laparoscopic and open gastric bypass surgery. Surg Innov. 2004 Dec;11(4):235-9. doi: 10.1177/155335060401100406. PubMed 15756392 ↗
  • Johnson JM, Maher JW, DeMaria EJ, Downs RW, Wolfe LG, Kellum JM. The long-term effects of gastric bypass on vitamin D metabolism. Ann Surg. 2006 May;243(5):701-4; discussion 704-5. doi: 10.1097/01.sla.0000216773.47825.c1. PubMed 16633006 ↗
  • Bond DS, Evans RK, DeMaria E, Wolfe L, Meador J, Kellum J, Maher J, Warren BJ. Physical activity and quality of life improvements before obesity surgery. Am J Health Behav. 2006 Jul-Aug;30(4):422-34. doi: 10.5555/ajhb.2006.30.4.422. PubMed 16787132 ↗
  • Jamal MK, DeMaria EJ, Johnson JM, Carmody BJ, Wolfe LG, Kellum JM, Meador JG. Impact of major co-morbidities on mortality and complications after gastric bypass. Surg Obes Relat Dis. 2005 Nov-Dec;1(6):511-6. doi: 10.1016/j.soard.2005.08.010. Epub 2005 Oct 27. PubMed 16925280 ↗
  • Jamal MK, DeMaria EJ, Johnson JM, Carmody BJ, Wolfe LG, Kellum JM, Meador JG. Insurance-mandated preoperative dietary counseling does not improve outcome and increases dropout rates in patients considering gastric bypass surgery for morbid obesity. Surg Obes Relat Dis. 2006 Mar-Apr;2(2):122-7. doi: 10.1016/j.soard.2006.01.009. PubMed 16925335 ↗
  • Bond DS, Evans RK, DeMaria EJ, Wolfe LG, Meador JG, Kellum JM, Maher JW. Physical activity stage of readiness predicts moderate-vigorous physical activity participation among morbidly obese gastric bypass surgery candidates. Surg Obes Relat Dis. 2006 Mar-Apr;2(2):128-32. doi: 10.1016/j.soard.2006.01.007. Epub 2006 Mar 3. PubMed 16925336 ↗
  • DeMaria EJ, Portenier D, Wolfe L. Obesity surgery mortality risk score: proposal for a clinically useful score to predict mortality risk in patients undergoing gastric bypass. Surg Obes Relat Dis. 2007 Mar-Apr;3(2):134-40. doi: 10.1016/j.soard.2007.01.005. PubMed 17386394 ↗
  • Lee S, Carmody B, Wolfe L, Demaria E, Kellum JM, Sugerman H, Maher JW. Effect of location and speed of diagnosis on anastomotic leak outcomes in 3828 gastric bypass cases. J Gastrointest Surg. 2007 Jun;11(6):708-13. doi: 10.1007/s11605-007-0085-3. PubMed 17562118 ↗
  • Lee SD, Khouzam MN, Kellum JM, DeMaria EJ, Meador JG, Wolfe LG, Maher JW. Selective, versus routine, upper gastrointestinal series leads to equal morbidity and reduced hospital stay in laparoscopic gastric bypass patients. Surg Obes Relat Dis. 2007 Jul-Aug;3(4):413-6. doi: 10.1016/j.soard.2007.04.006. Epub 2007 Jun 12. PubMed 17567540 ↗
  • Evans RK, Bond DS, Wolfe LG, Meador JG, Herrick JE, Kellum JM, Maher JW. Participation in 150 min/wk of moderate or higher intensity physical activity yields greater weight loss after gastric bypass surgery. Surg Obes Relat Dis. 2007 Sep-Oct;3(5):526-30. doi: 10.1016/j.soard.2007.06.002. PubMed 17903772 ↗
  • Maher JW, Martin Hawver L, Pucci A, Wolfe LG, Meador JG, Kellum JM. Four hundred fifty consecutive laparoscopic Roux-en-Y gastric bypasses with no mortality and declining leak rates and lengths of stay in a bariatric training program. J Am Coll Surg. 2008 May;206(5):940-4; discussion 944-5. doi: 10.1016/j.jamcollsurg.2007.12.043. Epub 2008 Mar 24. PubMed 18471729 ↗
  • Yuan X, Martin Hawver LR, Ojo P, Wolfe LM, Meador JG, Kellum JM, Maher JW. Bariatric surgery in Medicare patients: greater risks but substantial benefits. Surg Obes Relat Dis. 2009 May-Jun;5(3):299-304. doi: 10.1016/j.soard.2008.08.018. Epub 2008 Aug 30. PubMed 18996764 ↗
  • Bond DS, Phelan S, Wolfe LG, Evans RK, Meador JG, Kellum JM, Maher JW, Wing RR. Becoming physically active after bariatric surgery is associated with improved weight loss and health-related quality of life. Obesity (Silver Spring). 2009 Jan;17(1):78-83. doi: 10.1038/oby.2008.501. Epub 2008 Nov 6. PubMed 18997679 ↗
  • Maher JW, Bakhos W, Nahmias N, Wolfe LG, Meador JG, Baugh N, Kellum JM. Drain amylase levels are an adjunct in detection of gastrojejunostomy leaks after Roux-en-Y gastric bypass. J Am Coll Surg. 2009 May;208(5):881-4; discussion 885-6. doi: 10.1016/j.jamcollsurg.2008.12.022. Epub 2009 Mar 26. PubMed 19476853 ↗
  • Chikunguwo SM, Wolfe LG, Dodson P, Meador JG, Baugh N, Clore JN, Kellum JM, Maher JW. Analysis of factors associated with durable remission of diabetes after Roux-en-Y gastric bypass. Surg Obes Relat Dis. 2010 May-Jun;6(3):254-9. doi: 10.1016/j.soard.2009.11.003. Epub 2009 Nov 10. PubMed 20303324 ↗
  • Kellum JM, Chikunguwo SM, Maher JW, Wolfe LG, Sugerman HJ. Long-term results of malabsorptive distal Roux-en-Y gastric bypass in superobese patients. Surg Obes Relat Dis. 2011 Mar-Apr;7(2):189-93. doi: 10.1016/j.soard.2010.08.018. Epub 2010 Oct 11. PubMed 21145293 ↗
  • Browning MG, Baugh NG, Wolfe LG, Kellum JK, Maher JW, Evans RK. Evaluation of pre- and postoperative physical activity participation in laparoscopic gastric banding patients. Obes Surg. 2014 Nov;24(11):1981-6. doi: 10.1007/s11695-014-1283-1. PubMed 24831460 ↗
  • Browning MG, Khoraki J, DeAntonio JH, Mazzini G, Mangino MJ, Siddiqui MS, Wolfe LG, Campos GM. Protective effect of black relative to white race against non-alcoholic fatty liver disease in patients with severe obesity, independent of type 2 diabetes. Int J Obes (Lond). 2018 Apr;42(4):926-929. doi: 10.1038/ijo.2017.309. Epub 2017 Dec 21. PubMed 29437160 ↗
  • Khoraki J, Mazzini GS, Shah AS, Del Prado PAR, Wolfe LG, Campos GM. Early small bowel obstruction after laparoscopic gastric bypass: a surgical emergency. Surg Obes Relat Dis. 2018 Aug;14(8):1118-1125. doi: 10.1016/j.soard.2018.05.009. Epub 2018 May 23. PubMed 29945755 ↗
  • Pessoa BM, Browning MG, Mazzini GS, Wolfe L, Kaplan A, Khoraki J, Campos GM. Factors Mediating Type 2 Diabetes Remission and Relapse after Gastric Bypass Surgery. J Am Coll Surg. 2020 Jan;230(1):7-16. doi: 10.1016/j.jamcollsurg.2019.09.012. Epub 2019 Oct 28. PubMed 31672669 ↗
  • Mazzini GS, Khoraki J, Browning MG, Pessoa BM, Wolfe LG, Campos GM. Population Diversity Challenge the External Validity of the European Randomized Controlled Trials Comparing Laparoscopic Gastric Bypass and Sleeve Gastrectomy. Obes Surg. 2020 Mar;30(3):992-1000. doi: 10.1007/s11695-019-04247-y. PubMed 31768868 ↗
09

Timeline

1 registry update since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedDate before it movedWhere the date was before it movedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Started Jul 1980 (actual). Primary completion is estimated for Oct 2027, 567 months after the start.

Of 138 non-industry observational studies under Obesity, Morbid, half reached primary completion within 46 months of starting (the median), counting those still running; a quarter within 16 and three quarters within 132. This study's planned 567 months is above that.

Counting every sponsor, half of 139 studies reached it within 46 months; a quarter within 16 and three quarters within 132.

Since we started tracking on Sep 25, 2026, the dates moved once, on Nov 5, 2026: primary completion Oct 2026 → Oct 2027 and completion Oct 2026 → Oct 2027.

Earlier changes are on the record history on ClinicalTrials.gov ↗

How these figures are worked out, and which studies are left out of them.

Registered
Jan 20, 2010
First posted
Jan 25, 2010
StartActual
Jul 1, 1980
Primary completionEst.
Oct 2027was Oct 2026
CompletionEst.
Oct 2027was Oct 2026
Last update
Nov 5, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
Primary completion
Oct 2026→Oct 2027
Nov 5, 2026
Study completion
Oct 2026→Oct 2027
Nov 5, 2026
Show all 1 update
  1. Nov 5, 2026
    Primary completion Oct 2026→Oct 2027
    Study completion Oct 2026→Oct 2027
    + 1 other change: verification date

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

10

Registry details

Key details

Study ID
NCT01055054
Responsible party
Sponsor
First posted
Jan 25, 2010
Start date
Jul 1, 1980
Primary completion
Oct 2027 (estimated)
Completion
Oct 2027 (estimated)
Last update
Nov 5, 2026

Study contacts

Guilherme M Campos, MD
principal investigator · Virginia Commonwealth University

Oversight

Data monitoring committee
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

No contact was published for this record. The registry link below has the sponsor’s details.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion